Mammalian RIG-I-like receptors detect viral dsRNA and 5' triphosphorylated RNA to activate transcription of interferon genes and promote antiviral defense. The C. elegans RIG-I-like receptor DRH-1 promotes defense through antiviral RNA interference, but less is known about its role in regulating transcription. Here we describe a role for drh-1 in directing a transcriptional response in C. elegans called the Intracellular Pathogen Response (IPR), which is associated with increased pathogen resistance. The IPR includes a set of genes induced by diverse stimuli including intracellular infection and proteotoxic stress. Previous work suggested that the proteotoxic stress caused by intracellular infections might be the common trigger of the IPR, but here we demonstrate that different stimuli act through distinct pathways. Specifically, we demonstrate that DRH-1/RIG-I is required for inducing the IPR in response to Orsay virus infection, but not in response to other triggers like microsporidian infection or proteotoxic stress.
Introduction
RIG-I-like receptors (RLRs) are an ancient family of cytoplasmic pattern recognition receptors that detect viral dsRNA and 5' triphosphorylated RNA to trigger antiviral immune responses (Ahmad and Hur, 2015; Lässig and Hopfner, 2017) . In mammals this family includes RIG-I and MDA5, which contain a common N-terminal tandem caspase activation and recruitment domain (2CARD), a central DExD/H box motif helicase domain, and a zinc-binding C-terminal domain (CTD) (Yoneyama et al., 2005) . After the helicase and CTD bind to viral RNAs, these receptors trigger a signaling cascade via interaction of the CARD domain with the mitochondrial activator of virus signaling (MAVS) protein, which ultimately results in the activation of the IRF3 and NF-B transcription factors (Wu and Hur, 2015) . These transcription factors trigger downstream defense gene expression, including an IRF3-mediated antiviral type-I interferon response (Gebhardt et al., 2017) . Given the importance of RLRs in antiviral defense and autoimmunity, further understanding their evolution and signaling mechanisms in different contexts could provide new avenues for treatment of viral infections and autoimmune diseases.
RIG-I is one of the few pattern recognition receptors conserved between mammals and the model nematode C. elegans. Notably, C. elegans lacks the cytoplasmic pattern recognition receptors cGAS-STING and NLR proteins, and also lacks canonical Toll-like receptor/ NF-B signaling (Cohen and Troemel, 2015; Irazoqui et al., 2010; Pujol et al., 2001; Pukkila-Worley, 2016) . Furthermore, C. elegans lacks obvious homologs of IRF3 and MAVS as well as interferon ligands and receptors. However, C. elegans does possess three genes that encode RIG-I-like receptor homologs: dicer-related helicases 1, 2, and 3 (drh-1, drh-2, and drh-3) (Duchaine et al., 2006; Tabara et al., 2002) . Like RIG-I and MDA5, these genes encode helicase and CTD domains, but have a divergent N terminal domain. DRH-1 was originally identified in C. elegans as a protein that interacts with the dsRNA-binding protein RDE-4 and Dicer/DCR-1 to process dsRNA into siRNAs (Tabara et al., 2002) . Subsequently, drh-1 was found to mediate an antiviral response to several types of viral infection in C. elegans (Ashe et al., 2013; Coffman et al., 2017; Gammon et al., 2017; Guo et al., 2013; Lu et al., 2009 ). Functional analysis indicated that the helicase domain from human RIG-I could substitute for the helicase domain in C. elegans drh-1 to promote anti-viral defense against both of these infections (Guo et al., 2013) . Interestingly, a small deletion in the CTD of drh-1 was shown to underlie natural variation in C. elegans strains susceptible to infection by the Orsay virus (Ashe et al., 2013) . The Orsay virus has a positive sense ssRNA genome composed of just two segments, the RNA1 segment which contains an open reading frame (ORF) encoding an RNAdependent RNA polymerase (RDRP), and the RNA2 segment which contains an ORF encoding a capsid protein and an ORF implicated in viral exit (Félix et al., 2011; Yuan et al., 2018) .
Because C. elegans lacks interferon signaling, characterization of the antiviral mechanism of drh-1 has focused on its role in mediating antiviral RNA interference. The role for drh-1 in triggering a transcriptional response to viral infection has been less clear (Tanguy et al., 2017) .
Intriguingly, C. elegans responds to Orsay virus infection by upregulating mRNA expression of a set of genes that are also induced during infection with pathogens in the microsporidia phylum (Bakowski et al., 2014; Chen et al., 2017; Reddy et al., 2019) . Like viruses, microsporidia are obligate intracellular pathogens that are natural pathogens of the C. elegans intestine (Troemel et al., 2008) . However, microsporidia are molecularly distinct, as they are eukaryotic pathogens in the fungal kingdom. We have named the common transcriptional response to microsporidia and the Orsay virus the Intracellular Pathogen Response (IPR), as it appears to represent a novel stress/immune pathway including many genes upregulated in the intestine (Bakowski et al., 2014; Reddy et al., 2017) . The IPR is regulated by two members of the pals gene family, which is named for a protein signature of unknown biochemical function, and has a single member each in mouse and human (Leyva-Díaz et al., 2017; Reddy et al., 2017) . C. elegans mutants defective in the gene pals-22 constitutively express IPR genes, and have increased resistance to virus and microsporidia infection, which is reversed when increased IPR gene expression is suppressed by mutations in pals-25 (Reddy et al., 2019) . In addition to increased pathogen resistance, pals-22 mutants have several other phenotypes including increased thermotolerance dependent on ubiquitin ligase components, increased RNAi interference, increased susceptibility to the extracellular bacterial pathogen Pseudomonas aeruginosa, slowed development, and shortened lifespan (Leyva-Díaz et al., 2017; Reddy et al., 2017) . Thus, activation of IPR genes is associated with a broad rewiring of C. elegans physiology.
How are IPR genes induced? Given that they can be induced not just by infection, but also by proteotoxic stressors like prolonged heat stress and proteasome blockade, a simple hypothesis was that intracellular infections by microsporidia and virus were creating proteotoxic stress that led to IPR gene induction (Bakowski et al., 2014) . However, here we show that there are additional layers of complexity in the regulation of IPR induction. Specifically, we show that induction of IPR gene expression by viral infection requires the drh-1 receptor. drh-1 mutants are defective in inducing IPR genes in response to viral infection but not in response to other IPR triggers, including microsporidian infection and proteotoxic stress. Furthermore, we show that activation of this transcriptional response does not require known DRH-1 interacting proteins RDE-4 or DCR-1, and thus appears to occur via a mechanism that is distinct from the antiviral RNAi pathway. Finally, we use RNA-seq to show that the IPR transcriptional program can be induced by ectopic expression of the Orsay virus RNA1 segment, and this induction depends on RDRP activity and on drh-1. Together these results suggest that drh-1 acts a pattern recognition receptor in C. elegans to sense viral replication products and activate the IPR stress/immune program.
Results

The RIG-I ortholog drh-1 is required for induction of the Intracellular Pathogen Response by Orsay virus infection, but not by other stressors
Infection of C. elegans by the Orsay virus or by the microsporidian species N. parisii induces a common set of genes as part of the IPR, including the gene pals-5. While the pals-5 gene is of unknown function, the pals-5p::GFP reporter provides a convenient read-out for the IPR (Bakowski et al., 2014) . To investigate the role of drh-1 in inducing the IPR, we examined pals-5p::GFP expression in the background of a drh-1(ok3495) partial deletion allele. We found that, in contrast to wild-type animals, Orsay virus infection did not induce pals-5p::GFP reporter expression in drh-1(ok3495) mutants, despite these mutants carrying a higher viral load as assessed by qRT-PCR of the viral RNA1 genome segment (Figure 1a -c). Because the drh-1(ok3495) allele has only a partial deletion, we used CRISPR/Cas9 editing to generate an additional deletion allele of drh-1, in which the entire genomic locus was removed ( Figure 1d ). This complete deletion allele, drh-1(jy110), also failed to upregulate the IPR reporter when infected with Orsay virus (Figure 1e ) and carried a higher viral load compared to wild-type (WT) worms ( Figure 1f ). For simplicity, from this point onward the drh-1(ok3495) allele will be denoted as drh-1 (-) .
Interestingly, we found no defect in IPR reporter activation by N. parisii infection or proteasome blockade in either of the drh-1 mutant alleles, and we did not observe a substantial difference in N. parisii pathogen load in drh-1 mutants compared to WT controls ( Figure 2 ). Indeed, in both drh-1 deletion alleles proteasome blockade or N. parisii infection resulted in stronger GFP reporter activation than was seen in WT controls, with the effect stronger in the drh-1(jy110) complete deletion background (Figure 2a -f). We also saw robust activation by prolonged heat stress in both drh-1 mutant alleles (Figure 2g-h). Furthermore, the increased pals-5p::GFP expression seen in a pals-22 mutant background was not compromised by a mutation in drh-1 ( Figure 2i ), indicating that this pathway for IPR induction is not dependent on drh-1. Thus, we found that drh-1 is required specifically for pals-5p::GFP expression in response to viral infection, but not for response to other triggers of pals-5p::GFP expression.
drh-1 acts independently of known RNAi factors to induce IPR mRNA expression in response to Orsay virus infection
To obtain a broader picture of the requirement for drh-1 in IPR gene expression, we performed qRT-PCR analysis for a panel of IPR genes including those of unknown biochemical function pals-5 and F26F2.1, mRNA decapping enzyme eol-1, and ubiquitin ligase complex component skr-5 (Bakowski et al., 2014; Reddy et al., 2017 Reddy et al., , 2019 . As a negative control we included skr-1, which is a ubiquitin ligase complex component that is not induced upon infection (Bakowski et al., 2014; Reddy et al., 2017) . We compared expression levels in Orsay infected worms vs mock infected controls at 12 hours and 24 hours post-infection (hpi) in WT and drh-1(-) mutant backgrounds ( Figure 3 ). We observed that at 12 hpi there was a >10-fold induction of pals-5, F26F2.1, and eol-1 in the Orsay-infected WT worms, but no detectable induction in the drh-1 (-) background (Figure 3a ) despite the fact that they were carrying a much higher viral load than their WT counterparts ( Figure 3b ). We observed a similar pattern at 24 hpi, with pals-5, F26F2.1, and eol-1 being induced >100 fold by Orsay infection in the WT background, while much less induction was seen in the drh-1(-) background despite drh-1(-) carrying an increased viral load . No induction of skr-1 was observed in WT or drh-1(-) at 12 hpi or 24 hpi (Figure 3a, c) . In contrast to the lack of IPR induction in drh-1 mutants at 12 hpi, some induction of pals-5, F26F2.1 and eol-1 was observed in the drh-1 mutant background at 24 hpi, raising the possibility that there could be a drh-1-independent induction of IPR genes by Orsay virus that functions at later stages of infection or with higher viral loads. Of note, at 24 hpi skr-5 showed higher expression in the infected drh-1 mutants compared to infected WT (Figure 3c) demonstrating that unlike the other IPR genes assayed, skr-5 induction does not require drh-1.
Analysis of the drh-1(jy110) full deletion allele at 24 hpi confirmed these findings (Figure 3e -f).
Together, these data demonstrate that drh-1 is required to induce several IPR genes in response to Orsay virus infection.
We next investigated whether other components of the antiviral RNAi pathway play a role in the virus-induced activation of IPR gene expression. In addition to drh-1, the C. elegans genome encodes two other DExD/H box RNA helicases with homology to mammalian RLRs, drh-2 and drh-3 (Duchaine et al., 2006; Tabara et al., 2002) . DRH-2 is not thought to have a direct role in antiviral RNAi, but DRH-3 participates in the production of secondary siRNAs (Guo et al., 2013; Lu et al., 2009) . Other factors involved in the production of siRNAs targeting viral transcripts include RDE-4 and DCR-1, which both interact directly with DRH-1, potentially as part of the complex that binds viral dsRNAs to initiate cleavage, and RDE-1, an argonaute that binds primary siRNAs (Duchaine et al., 2006; Guo et al., 2019; Parrish and Fire, 2001; Tabara et al., 2002) . To test the role of these genes we infected rde-1, rde-4, drh-2, and drh-3 mutants with Orsay virus for 12 and 24 hpi (infections were performed in parallel with WT and drh-1(-) infections described above). qRT-PCR analysis for a panel of IPR genes showed that none of these other antiviral RNAi mutants had impaired upregulation of IPR gene expression in response to viral infection (Figure 3a , c). At both 12 and 24 hpi IPR gene expression levels were higher in rde-1, rde-4, and drh-3 mutants compared to WT, which is consistent with the higher viral load observed in these mutants (Figure 3b, d) . Importantly, drh-1 mutants attained a similar viral load to rde-1, rde-4, and drh-3 mutants at both time points, while displaying drastically less induction of IPR genes. (Figure 3a -d) . No defects in IPR activation were observed in drh-2 mutants, and they showed comparable viral loads to WT worms at both time points (Figure 3a Because null mutations in the C. elegans Dicer homolog dcr-1 lead to sterility or lethality (Billi et al., 2014) , we used RNAi knockdown to determine whether dcr-1 was required for IPR activation by Orsay virus. Worms raised on dcr-1 RNAi beginning at L1 stage and infected with Orsay virus at L4 showed higher levels of IPR activation at 24 hpi than worms raised on RNAi vector control and also carried a higher viral load (Figure 3g-i), indicating that dcr-1 is not required for IPR activation by Orsay virus. Altogether, these results indicate that drh-1, but not other canonical RNAi factors like dcr-1, are required for mediating induction of IPR gene expression upon viral infection.
IPR gene expression is induced in a manner dependent on drh-1 and on the activity of viral RNA-dependent RNA polymerase
Previous work indicated that transgenic expression and replication of only Orsay virus RNA1, the viral genome segment containing the RDRP, was sufficient to activate the pals-5p::GFP IPR reporter, and that this activation was lost when a mutation was introduced that ablated the polymerase activity of the RDRP (and therefore also ablated replication of the RNA1 segment) . Here we investigated whether this effect was dependent on drh-1. First, we compared IPR reporter expression in transgenic animals expressing Orsay RNA1(wt) or Orsay RNA1 D601A(RDRP defective mutant) under the control of a heat-shock promoter in a WT or drh-1 mutant background. We found that, in agreement with previous work, heat-shock induced expression and replication of the Orsay virus RNA1(wt) in the WT background led to an increase in IPR reporter expression, whereas ectopic expression of the RNA1(mt) did not ( Figure 4a ). Importantly, we found that in the drh-1 mutant background, neither the RNA1(wt) nor the RNA1(mt) construct was able to induce IPR reporter expression, indicating that pals-5p::GFP induction by Orsay virus RNA1(wt) is dependent on drh-1 (Figure 4a ). We tested the specificity of the requirement for drh-1 in activating the IPR in response to RNA1 RDRP activity by crossing the RNA1(wt) array into the rde-1, rde-4, and drh-3 mutant backgrounds. We found that neither rde-1, rde-4, nor drh-3 were required to induce pals-5p::GFP expression in response to heat-shock induced ORV RNA1(wt) expression ( Figure 4b ), confirming that IPR activation resulting from RNA1 RDRP activity occurs via a pathway distinct from the canonical antiviral RNAi pathway.
We next investigated whether other IPR genes are induced by expression of RNA1, and whether this induction is dependent on drh-1. We performed qRT-PCR on animals expressing RNA1(wt) and RNA1(mt) in both WT and drh-1(-) backgrounds. First, we found that ectopic expression of RNA1(wt) induced all IPR genes tested, and this induction was dependent on drh-1 ( Figure 4c ). Analysis of the Orsay RNA1 transcript levels showed that RNA1 accumulated to higher levels in the drh-1 mutants compared to WT controls (Figure 4d ), indicating that the lack of induction was not due to lack of this RNA1 trigger.
The full repertoire of IPR genes can be induced by Orsay virus RNA-dependent RNA polymerase activity, dependent on drh-1
Given that ectopic expression of RNA1(wt) was sufficient to induce expression of a subset of IPR genes (Figure 4c ), we examined the full transcriptomic response to RNA1(wt) expression using RNA-seq, and investigated whether responses were dependent on drh-1. To minimize the contribution of the RNAi pathway, we used the rde-1(ne219) RNAi-deficient mutant background for all of our comparisons. Specifically, we compared these strains: 1) rde-1(-); RNA1(wt), 2) rde-1(-); RNA1(mt), 3) drh-1(-); rde-1(-); RNA1(wt), and 4) drh-1(-); rde-1(-); RNA1(mt), and used heat shock to induce RNA1 expression in all strains before harvesting RNA for RNA-seq ( Figure 5a ). For simplicity, we refer to these strains as 1) drh-1(+) animals expressing RNA1(wt), 2) drh-1(+) animals expressing RNA1(mt), 3) drh-1(-) mutants expressing RNA1(wt), and 4) drh-1(-) mutants expressing RNA1(mt).
First, we used qRT-PCR to measure the level of RNA1 expressed in the triplicate RNA samples used for RNA-seq analysis of these four strains. Here we saw that the levels of RNA1 were much higher in animals expressing RNA1(wt) compared to RNA1(mt) (Figure 5b ), which is expected given that RNA1 is a polymerase that amplifies the copy number of RNA1. RNA1 expression levels were slightly higher on average in the drh-1(-) animals expressing RNA1(wt) compared to the drh-1(+) animals expressing RNA1(wt) (Figure 5b ). Then we performed RNAseq, and used multidimensional scaling analysis on the RNA-seq results to determine which strain had the most distinct gene expression profile. Here we found that mRNA expression in drh-1(+) animals expressing RNA1(wt) diverged most dramatically from mRNA expression in the other three strains (Figure 5c ), indicating a transcriptional response dependent on RDRP activity and wild-type drh-1.
When comparing drh-1(+) animals expressing RNA1(wt) to drh-1(+) animals expressing RNA1(mt), we found 194 genes significantly upregulated and 1 significantly downregulated Supplemental Table 1 ). Of these, only 26 genes were also significantly upregulated in drh-1(-) animals expressing RNA1(wt) vs. drh-1(-) animals expressing RNA1(mt) (Figure 6a b, Supplemental Table 2 ). These results indicate that the transcriptional response to RDRP activity is largely dependent on drh-1. Importantly, there was also a large degree of overlap between genes induced by RDRP activity and "canonical" IPR genes, which were defined by being induced by N. parisii infection and regulated by pals-22/25 (Reddy et al., 2019) . A majority of the IPR genes induced by RNA1(wt) were drh-1 regulated (Figure 6b , Supplemental table 2) .
For example, predicted ubiquitin ligase components like Cullin cul-6, which is required for increased thermotolerance in pals-22 mutants (Reddy et al., 2017) , as well as the Skp-related protein skr-4 and F-box protein fbxa-75, were induced by RNA1(wt) expression in a drh-1dependent manner ( Supplementary Table 2 ). We also compared the genes induced by RNA1 activity with a previously published data set of genes induced in the rde-1 mutant background by Orsay virus infection , and found that the majority of the RDRP activityinduced genes were also induced during natural Orsay infection (Figure 6a -c, Supplemental   Table 2 ). While there were genes listed as virally induced that were not significantly upregulated by expression of RNA1(wt), most of these were induced but failed to meet the significance cutoff ( Supplemental Table 3 ). Therefore, the IPR, which is a common response to molecularly divergent pathogens like microsporidia and virus, can be induced by expression of replicationcompetent Orsay RNA1 in a manner dependent on RDRP activity and drh-1.
Discussion
The field of innate immunity in C. elegans is only about 20 years old, and thus is relatively new compared to innate immunity research in other model hosts (Jiang and Wang, 2018; Kim and Ewbank, 2018; Leggewie and Schnettler, 2018; Xu and Cherry, 2014) . While the transcriptional responses to diverse pathogens have been described in C. elegans, the pattern recognition receptors that activate these responses have remained mostly unclear, with the exception of a G-protein-coupled receptor required to sense ligands induced by both wounding and a fungal infection that penetrates the epidermis (Kim and Ewbank, 2018; Zugasti et al., 2014) . Here we show that one of the only pattern recognition receptors conserved between mammals and C. elegans, DRH-1/RIG-I, appears to sense viral intermediates to trigger the IPR transcriptional program in the intestine, which is associated with increased defense against the Orsay virus and other intracellular pathogens (Reddy et al., 2019) . Importantly, the role of drh-1 in mediating the C. elegans transcriptional response to Orsay virus is separable from its role in antiviral RNAi, as neither of the two known direct binding partners of DRH-1, RDE-4 or DCR-1, nor other RNAi pathway components we tested, were required for IPR activation. Because the RDRP activity from the Orsay RNA1 segment appears to be required for activation, our results suggest that a viral replication intermediate, such as dsRNA or 5' triphosphate RNA, is the ligand that binds the DRH-1 receptor to activate the IPR (Figures 4-6 ). This pathogen ligand/patternrecognition receptor pair is one of the few that have paired together so far in C. elegans. Of note we found that microsporidia induction of the IPR is independent of drh-1, indicating that there are separate receptors yet to be identified that sense infection with these fungal-related pathogens. It is possible that microsporidia are sensed by the proteotoxic stress they cause during infection, although given the large number of effectors secreted by microsporidia (Reinke et al., 2017) , there may be also be receptors that sense specific microsporidia ligands to trigger the IPR.
What happens downstream of DRH-1 activation to induce IPR gene expression? C. elegans does not have clear homologs of MAVS, IRF3, or NF-κB, which activate the transcriptional program downstream of RIG-I-like receptors in mammals (Gebhardt et al., 2017) . Therefore, the signaling components that mediate this response in C. elegans are likely to be different. So far the only other host factors shown to regulate activation of the IPR are the antagonistic paralogs pals-22 and pals-25, which repress and activate the IPR respectively (Reddy et al., 2019) . drh-1 appears to act in parallel to both pals-22 and external triggers of the IPR like microsporidian infection and proteotoxic stress. These findings indicate that drh-1 is just one of multiple inputs to the IPR (Figure 7) . While constitutive activation of IPR gene expression in pals-22 mutants indicates that this transcriptional program provides anti-viral defense (Reddy et al., 2019) , the contribution of drh-1-mediated induction of this program is less clear. In previous studies it appeared that drh-1 might have a role independent of RNAi in anti-viral defense, as loss of both drh-1 and RNAi factors together had greater susceptibility to infection compared to loss of the RNAi factors alone (Ashe et al., 2013) . We also observed a trend towards higher accumulation of Orsay RNA1 transcripts in the rde-1(-); drh-1(-) double mutant background compared to the rde-1(-) single mutant background ( Figure 5B ), which would be consistent with this model.
Indeed, drh-1 does not appear to be required for antiviral siRNA biogenesis, but rather appears to regulate which regions of the viral RNA are converted into small interfering RNAs (Coffman et al., 2017) . It is not currently possible to completely separate the effects of drh-1 activity on RNAi from its effects on IPR activation, but it is possible that some of the viral susceptibility in drh-1 mutants that has been attributed to defects in antiviral RNAi could instead be due to defects in IPR activation.
In mammals, a prominent output of RIG-I signaling is transcriptional upregulation of interferon genes that encode ligands to activate interferon receptors and downstream signaling. Because C. elegans lacks interferon orthologs, it will be interesting to determine the nature of IPR effectors and how they regulate resistance. Of note, C. elegans does have homologs of the STAT transcription factors, which act downstream of the interferon receptor in mammals to activate interferon-stimulated genes and promote anti-viral defense (Dierking et al., 2011; Schneider et al., 2014; Wang and Levy, 2006) . Surprisingly, the sta-1 STAT transcription factor appears to repress expression of viral-response genes, and sta-1 mutants are resistant to infection (Tanguy et al., 2017) . This result highlights another difference between mammals and C. elegans in terms of the signaling events downstream of RIG-I recognition of viral infection.
One intriguing theme in common between RIG-I/IPR signaling in C. elegans and RIG-I/interferon response in mammals is that defects in the proteasome are associated with both responses.
Previous work in C. elegans demonstrated that either genetic or pharmacological block of the proteasome will activate IPR gene expression, in a manner independent of canonical proteostasis factors like the SKN-1/Nrf2 transcription factor (Bakowski et al., 2014; Reddy et al., 2019) . In humans, mutations in the proteasome, as well as gain-of-function mutations in RIG-I-like receptors, can lead to inappropriate activation of type-I interferon responses and autoimmunity (Brehm et al., 2015) . These defects are part of a group of diseases called interferonopathies, which are associated with upregulation of interferon, although it is controversial whether interferon is causal for these diseases (Kretschmer and Lee-Kirsch, 2017; Uggenti et al., 2019) . Therefore, it is possible that mammalian RIG-I triggers an interferon-independent output similar to the IPR that promotes both immunity as well as damaging inflammation. In light of this idea, it is interesting to note that constitutive activation of the IPR in pals-22 mutants is associated with increased immunity but also fitness defects such as shortened lifespan and premature aging (Reddy et al., 2017) . Therefore, further analysis of the regulation and outputs of the IPR may shed light on the interplay between viral infection, immunity and the negative consequences of hyper-activation of immune responses.
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Figure 5: Characterization of the transcriptional response to Orsay RNA1
A) Schematic of sample preparation for RNA-seq. Synchronized populations of L1 larvae for all four genotypes (drh-1(+); RNA1(mt), drh-1(+); RNA1(wt), drh-1(-); RNA1(mt), and drh-1(-); RNA1(wt)) were obtained by COPAS Biosort-based isolation of animals with the transgenic array marker myo-2p::YFP to obtain a relatively pure population of transgene-positive animals.
After sorting, worms were plated with food and incubated at 20°C for 2 days until the L4 stage.
At the L4 stage, worms were subjected to 2h heat shock at 34°C to induce expression of RNA1.
Worms were recovered at 20°C for 6h, then harvested for RNA isolation. B) qRT-PCR analysis of RNA1 transcript levels in samples used for RNA-seq. RNA1 transcript levels are compared to RNA1 levels in drh-1(+); RNA1(mt). Graph shows combined results for all three RNA-seq replicates, bars represent mean and error bars represent SD. C) MDS plot of all three RNA-seq replicates.
Figure 6: Ectopic expression of Orsay RNA1 induces IPR gene repertoire in an RDRPdependent and drh-1-dependent manner
A) Heat map showing top (p<0.003) differentially expressed genes in drh-1(+); RNA1(wt) vs drh-1(+); RNA1(mt). (*) denotes pseudogenes. Columns indicate whether gene was also differentially expressed in drh-1(-); RNA1(wt) vs drh-1(-); RNA1(mt), and whether gene was also differentially expressed in Orsay infected rde-1 mutant data set . B) Overlap between genes significantly upregulated by RNA1(wt) in the drh-1(+) background with canonical IPR genes and between genes significantly upregulated by RNA1(wt) in the drh-1 (-) background. C) Overlap between genes significantly upregulated by RNA1(wt) in the drh-1(+) background with canonical IPR genes and between genes significantly upregulated by Orsay infection from Chen et al 2017.
Figure 7: Model of DRH-1 mediated IPR activation by Orsay virus
Orsay virus infection in C. elegans is detected by DRH-1 recognition of viral replication intermediates produced by Orsay RNA-dependent RNA polymerase activity. DRH-1 signals downstream to activate the transcription of the protective IPR response. In parallel, DRH-1 also participates in the production of antiviral RNAi. The IPR can also be triggered by microsporidian infection, prolonged heat stress, proteasome blockade, and mutations in pals-22. Unlike viral infection, these triggers do not require DRH-1.
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Materials and Methods
C. elegans strains and maintenance
C. elegans were maintained on nematode growth media (NGM) plates seeded with OP50 E. coli as previously described (Brenner, 1974) . Worms were maintained at 20°C unless otherwise noted. See Table 1 for list of all C. elegans strains used in this study.
CRISPR deletion of drh-1 locus
To generate a mutant with a deletion of the entire drh-1 genomic locus we used the CRISPR coconversion strategy (Arribere et al., 2014) . Two crRNAs targeting either side of the drh-1 genomic locus were designed using Chopchop (https://chopchop.cbu.uib.no/): GCGTCTCTCTACTAATACAC and GGTTTTGGTCATCTTGATGT. drh-1 crRNAs, dpy-10 crRNA, and tracrRNA were obtained from IDT and resuspended in IDT nuclease-free duplex buffer. CRISPR injection mix was constructed containing 0.5 µl 100µM dpy-10 crRNA, 0.5 µl 100 µM drh-1 crRNAs, 2.5 µl 100 µM tracrRNA tracrRNA, and 3.5 µl Cas9 (QB3 MacroLab).
The Cas9 mixture was then injected into the gonad of approximately 30 young adult N2 worms.
Injected worms were singled onto individual NGM OP50 plates and incubated at 20°C for 3-4 days. Plates with a large number of F1 progeny showing the Dpy phenotype were identified, and >100 individual Dpy+ F1 progeny were picked to individual plates. Once F1 progeny had laid eggs, they were lysed and genotyped for the deletion of the drh-1 locus using primers deletion external forward: CTCGTCACCAGTGCGAAATA and deletion internal reverse:
CCAACCGCAATTCCAACATC. Presence of the complete deletion was confirmed with Sanger sequencing, and the allele was designated drh-1(jy110) . The dpy-10 mutation was crossed out of the drh-1(jy110) background, and drh-1(jy110) mutants were backcrossed three times to N2 prior to use in experiments.
Orsay virus filtrate preparation
Orsay virus filtrates were prepared as previously described (Félix et al., 2011) . Briefly, infected rde-1(ne219) worms were grown on standard NGM OP50 plates until just starved, then washed off plates using M9 buffer and disrupted with silicon beads. The homogenate was then filtered through a 0.22 µm filter and aliquots flash frozen in liquid nitrogen.
Orsay virus infection
For L1 infection (Figure 1a ), adults were bleached to obtain synchronized L1 larvae, which were then mixed with 10X concentrated OP50 E. coli and 1:50 diluted Orsay virus filtrate. Then, 500 µL total volume of L1/food/virus mix was plated onto 6 cm unseeded NGM plates and dried in a laminar flow hood. Infected worms were then incubated at 20°C until collection.
For L2 infection (Figure 1b-f ), bleached L1 larvae were plated on 6cm NGM plates containing a lawn of OP50 E. coli and incubated at 20°C overnight prior to infection. Orsay virus filtrate was then diluted in M9 at a ratio of 1:50. 300 µl of 1:50 diluted filtrate was top-plated onto the plates, which were then dried in a laminar flow hood. Infected worms were incubated at 20°C for 24h prior to collection.
For L4 infection (Figure 3) , 10 µL of Orsay filtrate was mixed with 300 µL of 10X concentrated OP50 E. coli and 190 µL M9, and 500 µL of this mixture was seeded onto 6 cm NGM plates and dried in a laminar flow hood. L4 stage worms (bleached L1 larvae plated on standard 6 cm OP50 plates and incubated at 20°C for 2 days) were washed off plates using M9 + 0.1% Triton X-100 (TX-100), counted, and re-plated onto plates seeded with Orsay filtrate mix. Infected worms were incubated at 20°C for the indicated amount of time prior to collection.
pals-5p::GFP quantification
pals-5p::GFP quantification by worm sorter (Figure 1, Figure 2a -h) :
Worms were washed off plates into microcentrifuge tubes using M9 + 0.1% TX-100, then washed 3X with M9 + 0.1% TX-100. Worms were concentrated into 150-200 µl, and transferred into 96 well cell culture plates. Worms were then analyzed using a COPAS Biosort (Union Biometrica) to record time of flight (TOF) and green fluorescence for each worm. GFP signal was normalized to worm size by dividing fluorescence by TOF for each worm. pals-5p::GFP quantification by ImageJ (Figure 2i, Figure 3a- 
Worms were collected and washed as described above, then paralyzed by adding 2 µL 5M Sodium Azide. Worms were then mounted on 2% agarose pads on glass slides, sealed with coverslip, and imaged using a Zeiss AxioImager M1 upright fluorescent microscope with a 10X objective. Signal was collected for DIC, YFP (co-injection marker for heat shock Orsay RNA1 expression array), GFP (pals-5p::GFP), and mCherry (pals-5p::GFP co-injection maker).
Identical exposure times were used for all images within an experiment. GFP signal in the intestine of individual worms was quantified using ImageJ (https://imagej.nih.gov/ij/). Mean grey values for each intestine were normalized by subtracting mean grey value from the image background.
N. parisii infection
N. parisii ERTm1 spore filtrate was prepared as previously described (Estes et al., 2011) . 1200 bleached L1 larvae were combined with 500,000 ERTm1 spores and 150 µl 10X concentrated OP50 E. coli and M9 buffer to a total volume of 300 µl, then seeded onto 6 cm NGM plates and dried in a laminar flow hood. ERTm1 infected worms were incubated at 25°C for 30 h prior to collection.
N. parisii pathogen load
N. parisii pathogen load was assessed by FISH staining as previously described (Reddy et al., 2019) . Briefly, infected worms were fixed in 4% paraformaldehyde, then hybridized with a CalFluor610-tagged FISH probe (Biosearch) specific for N. parisii rRNA. FISH stained worms were analyzed using a COPAS Biosort (Union Biometrica) to record TOF and red fluorescence for each individual worm. Signal was normalized to worm size by dividing red fluorescence over TOF for each worm.
Bortezomib treatment
Bleached L1 larvae were plated onto 6 cm NGM plates containing a lawn of OP50 E. coli and incubated at 20°C overnight. A 10 µM stock solution of bortezomib (Selleck Chemicals) resuspended in DMSO was mixed with M9 and top-plated onto plates for a final concentration of 2.5 µM bortezomib per plate. Control plates were top-plated with an equal amount of DMSO in M9. Plates were then incubated at 20°C for 24h prior to analysis with the COPAS Biosort (Union Biometrica).
Prolonged heat stress
Bleached L1 larvae were plated onto 6 cm NGM plates containing a lawn of OP50 E. coli and incubated at 20°C overnight. Experimental plates were then incubated at 28°C for 24 h, while control plates remained at 20°C. Worms were analyzed after 24 h using the COPAS Biosort (Union Biometrica).
qRT-PCR
Worms were washed off plates and washed with M9, then concentrated into <50 µl. Worms were homogenized in TRI Reagent (Molecular Research Center, Inc.) and frozen at -80°C. RNA was extracted using TRI Reagent and 1-bromo-3-chloropropane (BCP) (Molecular Research Center, http://www.mrcgene.com) according to the manufacturer's instructions. cDNA was prepared from total RNA using either SuperScript VILO (ThermoFisher) or iScript (Bio-Rad) cDNA synthesis kits. qRT-PCR was performed using iQ SYBR Green Supermix (Bio-Rad) on a CFX Connect Real Time System. Each experimental replicate was measured in technical duplicate. All gene expression was normalized to snb-1 expression, which does not change upon conditions tested. For comparisons in strains containing the Ex[HSP::RNA1] arrays, gene expression was additionally normalized to yfp expression to control for array mosaicism and differing numbers of array-containing animals in the test populations. The Pffafl method was used for quantifying gene expression changes (Pfaffl, 2001) . For list of qRT-PCR primers, see Table 2 .
dcr-1 RNAi treatment
Overnight cultures of Ahringer library dcr-1 E. coli RNAi clone or RNAi vector control L4440 E. coli. clone in the HT115 bacterial strain were seeded onto 6 cm NGM plates supplemented with 5 mM IPTG and 1 mM carbenicillin and incubated at room temperature for 1 day. Synchronized L1 larvae obtained by bleaching were plated on RNAi E. coli lawns and grown for 48h at 20°C. 300 µl of 1:50 diluted Orsay virus filtrate was top-plated onto the plates, and plates dried in a laminar flow hood. Infected worms were incubated at 20°C for 24 h prior to collection
HSP::RNA1 heat shock induction
Bleached L1 larvae were plated on 6 cm NGM plates containing a lawn of OP50 E. coli and incubated at 20°C for 2 days (until L4 stage). At L4 stage, plates were heat shocked at 34°C for 2 h, then allowed to recover at 20°C for 6 h prior to collection.
RNA-seq sample preparation and sequencing
Bleached L1 larvae were sorted using a COPAS Biosort (Union Biometrica) to obtain a population enriched for the Ex[HSP::RNA1(wt)] or Ex[HSP::RNA1(mt)] extrachromosomal array.
Array-positive larvae were sorted to unseeded 10 cm NGM worm plates at a density of ~2000 worms/plate, and 1 ml 10X concentrated OP50 E. coli was added after sorting was complete.
Plates were incubated at 20°C for 48 hours, until L4 stage. At L4 stage, plates were heat shocked at 34°C for 2h, then allowed to recover at 20°C for 6h prior to collection. Worms were washed off plates and washed 3X with M9, then concentrated into < 50 µl. Worms were then homogenized in 1mL TRI Reagent (Molecular Research Center, Inc.) and frozen at -80°C. RNA was extracted using TRI Reagent and 1-bromo-3-chloropropane (BCP) (Molecular Research Center, http://www.mrcgene.com) according to the manufacturer's instructions, and additionally purified using the RNeasy clean-up kit with on-column DNase I digestion (Qiagen). RNA quality was assessed by TapeStation at the UC San Diego Institute for Genomic Medicine. Sequencing libraries were constructed using the Truseq stranded mRNA method (Illumina), and sequenced SR75 on an Illumina HiSeq4000 sequencer (Illumina).
RNA-seq analysis
RNA-seq analysis was performed by the Center for Computational Biology and Bioinformatics at UC San Diego. Quality control of the raw fastq files was performed using the software tool FastQC (Andrews, 2010) v0.11.3. Sequencing reads were trimmed with Trimmomatic (Bolger et al., 2014) v0.36 and aligned to the C. elegans genome WBcel235 (Zerbino et al., 2018) using the STAR aligner (Dobin et al., 2013) v2.5.3a. Read quantification was performed with RSEM (Li and Dewey, 2011) v1.3.0 and the WBcel235 v96 annotation (Frankish et al., 2019) . The R BioConductor packages edgeR and limma (Ritchie et al., 2015) were used to implement the limma-voom (Law et al., 2014) method for differential expression analysis. In brief, lowly expressed genes-those not having counts per million (cpm)  1 in at least 1 of the samples-were filtered out and then trimmed mean of M-values (TMM) (Robinson and Oshlack, 2010) normalization was applied. The experimental design was modeled upon genotype and treatment (~0 + genotype + treatment). The voom method was employed to model the mean-variance relationship in the log-cpm values, after which lmFit was used to fit per-gene linear models and empirical Bayes moderation was applied with the eBayes function.
Significance was defined by using an adjusted p-value cut-off of 0.05 after multiple testing correction (Benjamini and Hochberg, 1995) using a moderated t-statistic in limma. For gene lists, Wormbase version WS270 was used to remove dead genes and update gene names.
Statistics
Statistics were performed using Prism 7. Collect RNA for sequencing GACGCTTCCAAGATTGGTATTGGT
